Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Trial Identifier: D5570C00002
Sponsor: AstraZeneca
Collaborator:
Juvenile Diabetes Research Foundation
NCTID:: NCT02500979
Start Date: August 2015
Primary Completion Date: August 2016
Study Completion Date: August 2016
Condition: Diabetes: Type 1

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English translation

Trial Locations

Country Location
United States of America, CA Chula Vista, CA, United States of America, 91911
United States of America, OR Portland, OR, United States of America, 97239
United States of America, TN Chattanooga, TN, United States of America, 37411